Home > > > Report Detail

Global Induced Pluripotent Stem Cells (iPSCs) Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 28-Jun-2021
No. of pages: 98
Inquire Before Buying

Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery. This may be particularly important in the context of monogenic rare hereditary diseases, where iPSCs can provide an alternative model system to compensate for the lack of a predictive in-vitro human model for drug discovery.

The industry's leading manufacturers are Fujifilm Holding Corporation (CDI), Ncardia and Sumitomo Dainippon Pharma, which accounted for 39.31 percent, 20.24 percent and 13.67 percent of revenue, respectively.

Market Analysis and Insights: Global Induced Pluripotent Stem Cells (iPSCs) Market

The global Induced Pluripotent Stem Cells (iPSCs) market size is projected to reach US$ 202.9 million by 2027, from US$ 90 million in 2020, at a CAGR of 12.3% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Induced Pluripotent Stem Cells (iPSCs) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Induced Pluripotent Stem Cells (iPSCs) market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Induced Pluripotent Stem Cells (iPSCs) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Induced Pluripotent Stem Cells (iPSCs) market.

Global Induced Pluripotent Stem Cells (iPSCs) Scope and Market Size

Induced Pluripotent Stem Cells (iPSCs) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Induced Pluripotent Stem Cells (iPSCs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Human iPSCs

- Mouse iPSCs

- Human iPSCs had a market share of 89.65% in 2019, followed by Mouse iPSCs.

Segment by Application

- Academic Research

- Drug Development and Discovery

- Toxicity Screening

- Regenerative Medicine

- Others

- Academic Research is the largest segment of Induced Pluripotent Stem Cells (iPSCs) application,with a share of 32% in 2019.

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Fujifilm Holding Corporation (CDI)

- Ncardia

- Sumitomo Dainippon Pharma

- Astellas Pharma Inc

- Fate Therapeutics, Inc

- Pluricell Biotech

- Cell Inspire Biotechnology

- ReproCELL

Global Induced Pluripotent Stem Cells (iPSCs) Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Human iPSCs
1.2.3 Mouse iPSCs
1.3 Market by Application
1.3.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Academic Research
1.3.3 Drug Development and Discovery
1.3.4 Toxicity Screening
1.3.5 Regenerative Medicine
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Perspective (2016-2027)
2.2 Induced Pluripotent Stem Cells (iPSCs) Growth Trends by Regions
2.2.1 Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Induced Pluripotent Stem Cells (iPSCs) Historic Market Share by Regions (2016-2021)
2.2.3 Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Regions (2022-2027)
2.3 Induced Pluripotent Stem Cells (iPSCs) Industry Dynamic
2.3.1 Induced Pluripotent Stem Cells (iPSCs) Market Trends
2.3.2 Induced Pluripotent Stem Cells (iPSCs) Market Drivers
2.3.3 Induced Pluripotent Stem Cells (iPSCs) Market Challenges
2.3.4 Induced Pluripotent Stem Cells (iPSCs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Revenue
3.1.1 Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Revenue (2016-2021)
3.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Players (2016-2021)
3.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Induced Pluripotent Stem Cells (iPSCs) Revenue
3.4 Global Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio
3.4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Induced Pluripotent Stem Cells (iPSCs) Revenue in 2020
3.5 Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Area Served
3.6 Key Players Induced Pluripotent Stem Cells (iPSCs) Product Solution and Service
3.7 Date of Enter into Induced Pluripotent Stem Cells (iPSCs) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Induced Pluripotent Stem Cells (iPSCs) Breakdown Data by Type
4.1 Global Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Type (2016-2021)
4.2 Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Type (2022-2027)
5 Induced Pluripotent Stem Cells (iPSCs) Breakdown Data by Application
5.1 Global Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Application (2016-2021)
5.2 Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size (2016-2027)
6.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
6.2.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021)
6.2.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027)
6.2.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2027)
6.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
6.3.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021)
6.3.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027)
6.3.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2027)
6.4 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
6.4.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021)
6.4.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size (2016-2027)
7.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
7.2.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021)
7.2.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027)
7.2.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2027)
7.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
7.3.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021)
7.3.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027)
7.3.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2027)
7.4 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
7.4.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021)
7.4.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size (2016-2027)
8.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
8.2.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2027)
8.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
8.3.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2027)
8.4 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region
8.4.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size (2016-2027)
9.2 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
9.2.1 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021)
9.2.2 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027)
9.2.3 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2027)
9.3 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
9.3.1 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021)
9.3.2 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027)
9.3.3 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2027)
9.4 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
9.4.1 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021)
9.4.2 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size (2016-2027)
10.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
10.2.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2027)
10.3 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
10.3.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2027)
10.4 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
10.4.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Fujifilm Holding Corporation (CDI)
11.1.1 Fujifilm Holding Corporation (CDI) Company Details
11.1.2 Fujifilm Holding Corporation (CDI) Business Overview
11.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Introduction
11.1.4 Fujifilm Holding Corporation (CDI) Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)
11.1.5 Fujifilm Holding Corporation (CDI) Recent Development
11.2 Ncardia
11.2.1 Ncardia Company Details
11.2.2 Ncardia Business Overview
11.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Introduction
11.2.4 Ncardia Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)
11.2.5 Ncardia Recent Development
11.3 Sumitomo Dainippon Pharma
11.3.1 Sumitomo Dainippon Pharma Company Details
11.3.2 Sumitomo Dainippon Pharma Business Overview
11.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Introduction
11.3.4 Sumitomo Dainippon Pharma Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)
11.3.5 Sumitomo Dainippon Pharma Recent Development
11.4 Astellas Pharma Inc
11.4.1 Astellas Pharma Inc Company Details
11.4.2 Astellas Pharma Inc Business Overview
11.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Introduction
11.4.4 Astellas Pharma Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)
11.4.5 Astellas Pharma Inc Recent Development
11.5 Fate Therapeutics, Inc
11.5.1 Fate Therapeutics, Inc Company Details
11.5.2 Fate Therapeutics, Inc Business Overview
11.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Introduction
11.5.4 Fate Therapeutics, Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)
11.5.5 Fate Therapeutics, Inc Recent Development
11.6 Pluricell Biotech
11.6.1 Pluricell Biotech Company Details
11.6.2 Pluricell Biotech Business Overview
11.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Introduction
11.6.4 Pluricell Biotech Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)
11.6.5 Pluricell Biotech Recent Development
11.7 Cell Inspire Biotechnology
11.7.1 Cell Inspire Biotechnology Company Details
11.7.2 Cell Inspire Biotechnology Business Overview
11.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Introduction
11.7.4 Cell Inspire Biotechnology Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)
11.7.5 Cell Inspire Biotechnology Recent Development
11.8 ReproCELL
11.8.1 ReproCELL Company Details
11.8.2 ReproCELL Business Overview
11.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Introduction
11.8.4 ReproCELL Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)
11.8.5 ReproCELL Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Human iPSCs
Table 3. Key Players of Mouse iPSCs
Table 4. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Regions (2016-2021)
Table 8. Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Regions (2022-2027)
Table 10. Induced Pluripotent Stem Cells (iPSCs) Market Trends
Table 11. Induced Pluripotent Stem Cells (iPSCs) Market Drivers
Table 12. Induced Pluripotent Stem Cells (iPSCs) Market Challenges
Table 13. Induced Pluripotent Stem Cells (iPSCs) Market Restraints
Table 14. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Players (2016-2021)
Table 16. Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Induced Pluripotent Stem Cells (iPSCs) as of 2020)
Table 17. Ranking of Global Top Induced Pluripotent Stem Cells (iPSCs) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Induced Pluripotent Stem Cells (iPSCs) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Induced Pluripotent Stem Cells (iPSCs) Product Solution and Service
Table 21. Date of Enter into Induced Pluripotent Stem Cells (iPSCs) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2016-2021)
Table 25. Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2016-2021)
Table 29. Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2022-2027) & (US$ Million)
Table 61. Fujifilm Holding Corporation (CDI) Company Details
Table 62. Fujifilm Holding Corporation (CDI) Business Overview
Table 63. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product
Table 64. Fujifilm Holding Corporation (CDI) Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) & (US$ Million)
Table 65. Fujifilm Holding Corporation (CDI) Recent Development
Table 66. Ncardia Company Details
Table 67. Ncardia Business Overview
Table 68. Ncardia Induced Pluripotent Stem Cells (iPSCs) Product
Table 69. Ncardia Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) & (US$ Million)
Table 70. Ncardia Recent Development
Table 71. Sumitomo Dainippon Pharma Company Details
Table 72. Sumitomo Dainippon Pharma Business Overview
Table 73. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product
Table 74. Sumitomo Dainippon Pharma Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) & (US$ Million)
Table 75. Sumitomo Dainippon Pharma Recent Development
Table 76. Astellas Pharma Inc Company Details
Table 77. Astellas Pharma Inc Business Overview
Table 78. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product
Table 79. Astellas Pharma Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) & (US$ Million)
Table 80. Astellas Pharma Inc Recent Development
Table 81. Fate Therapeutics, Inc Company Details
Table 82. Fate Therapeutics, Inc Business Overview
Table 83. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product
Table 84. Fate Therapeutics, Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) & (US$ Million)
Table 85. Fate Therapeutics, Inc Recent Development
Table 86. Pluricell Biotech Company Details
Table 87. Pluricell Biotech Business Overview
Table 88. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product
Table 89. Pluricell Biotech Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) & (US$ Million)
Table 90. Pluricell Biotech Recent Development
Table 91. Cell Inspire Biotechnology Company Details
Table 92. Cell Inspire Biotechnology Business Overview
Table 93. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product
Table 94. Cell Inspire Biotechnology Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) & (US$ Million)
Table 95. Cell Inspire Biotechnology Recent Development
Table 96. ReproCELL Company Details
Table 97. ReproCELL Business Overview
Table 98. ReproCELL Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021) & (US$ Million)
Table 99. ReproCELL Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Type: 2020 VS 2027
Figure 2. Human iPSCs Features
Figure 3. Mouse iPSCs Features
Figure 4. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application: 2020 VS 2027
Figure 5. Academic Research Case Studies
Figure 6. Drug Development and Discovery Case Studies
Figure 7. Toxicity Screening Case Studies
Figure 8. Regenerative Medicine Case Studies
Figure 9. Others Case Studies
Figure 10. Induced Pluripotent Stem Cells (iPSCs) Report Years Considered
Figure 11. Global Induced Pluripotent Stem Cells (iPSCs) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Induced Pluripotent Stem Cells (iPSCs) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Regions: 2020 VS 2027
Figure 14. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Regions (2022-2027)
Figure 15. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Players in 2020
Figure 16. Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Induced Pluripotent Stem Cells (iPSCs) as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Induced Pluripotent Stem Cells (iPSCs) Revenue in 2020
Figure 18. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2016-2021)
Figure 19. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2022-2027)
Figure 20. North America Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2016-2027)
Figure 22. North America Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2016-2027)
Figure 23. North America Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2016-2027)
Figure 24. United States Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2016-2027)
Figure 28. Europe Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2016-2027)
Figure 29. Europe Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2016-2027)
Figure 30. Germany Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Share by Region (2016-2027)
Figure 40. China Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2016-2027)
Figure 48. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2016-2027)
Figure 49. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2016-2027)
Figure 50. Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2016-2027)
Figure 56. Turkey Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Fujifilm Holding Corporation (CDI) Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)
Figure 60. Ncardia Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)
Figure 61. Sumitomo Dainippon Pharma Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)
Figure 62. Astellas Pharma Inc Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)
Figure 63. Fate Therapeutics, Inc Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)
Figure 64. Pluricell Biotech Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)
Figure 65. Cell Inspire Biotechnology Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)
Figure 66. ReproCELL Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs